Tobira Therapeutics

Developer of therapeutics to treat liver disease, human immunodeficiency virus, or HIV-1, fibrosis, and inflammation

placeSan Francisco, California, United States calendar_todayFounded 2007 language tobiratherapeutics.com

Registered entities

Investor mix

10 investors on record; 3 have since exited.

Investor typeCountShare
Venture capital660%
Private equity220%
Bank & private debt110%
Other / undisclosed110%
Coming soon